id,pert_id,pert_iname,cell_iname,pert_type,pert_idose,pert_itime,nsample,ss_ngene,cc_q75,tas,qc_pass,is_hiq,is_ncs_sig,is_exemplar_sig,is_null_sig,moa,target_name,raw_cs,fdr_q_nlog10,norm_cs
CPC006_HA1E_24H:N01,BRD-A71390734,idarubicin,HA1E,trt_cp,0.08 uM,24 h,3,449,0.671,0.555028,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.983,15.6536,-1.9491
CPC006_A375_6H:N01,BRD-A71390734,idarubicin,A375,trt_cp,0.08 uM,6 h,5,468,0.6227,0.545875,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.9773,15.6536,-1.9376
LPROT002_NPC.TAK_6H:BRD-K37798499:5,BRD-K37798499,etoposide,NPC,trt_cp,4 uM,6 h,3,281,0.56,0.401123,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.9741,15.6536,-1.9314
REP.B011_HUVEC.A_24H:P19,BRD-A33280134,etoposide,HUVEC,trt_cp,2.22 uM,24 h,2,239,0.3797,0.304614,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.9725,15.6536,-1.9282
LJP006_LNCAP_24H:C22,BRD-K21680192,mitoxantrone,LNCAP,trt_cp,0.37 uM,24 h,2,319,0.6806,0.471164,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.9723,15.6536,-1.9277
CPC013_A375_6H:BRD-K56334280-001-01-0:10,BRD-K56334280,amonafide,A375,trt_cp,10 uM,6 h,3,354,0.54,0.442109,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.9706,15.6536,-1.9243
CRCGN015_MCF10A_48H:BRD-K68346641:10.794,BRD-K68346641,amsacrine,MCF10A,trt_cp,10 uM,48 h,3,413,0.57,0.490617,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.9662,15.6536,-1.9157
REP.B023_HUVEC.A_24H:O13,BRD-K72951360,valrubicin,HUVEC,trt_cp,2.22 uM,24 h,2,244,0.3728,0.304974,0,0,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.963,15.6536,-1.9094
REP.A023_A375_24H:O15,BRD-K72951360,valrubicin,A375,trt_cp,1.11 uM,24 h,3,577,0.766,0.672253,1,1,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.9606,15.6536,-1.9046
CPC011_A549_24H:BRD-K37798499-001-13-2:10,BRD-K37798499,etoposide,A549,trt_cp,10 uM,24 h,3,346,0.58,0.452984,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.96,15.6536,-1.9034
CPC006_HA1E_24H:F17,BRD-A35588707,teniposide,HA1E,trt_cp,1.25 uM,24 h,3,524,0.6738,0.600844,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.9593,15.6536,-1.902
PAC003_U2OS_6H:BRD-K37798499-001-02-5:3.39814,BRD-K37798499,etoposide,U2OS,trt_cp,3.33 uM,6 h,2,111,0.41,0.215717,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.9593,15.6536,-1.9019
CPC006_MCF7_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,MCF7,trt_cp,1.25 uM,6 h,5,331,0.46,0.394569,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.9575,15.6536,-1.8983
REP.A023_MCF7_24H:O14,BRD-K72951360,valrubicin,MCF7,trt_cp,3.33 uM,24 h,3,494,0.7493,0.615208,1,1,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.9566,15.6536,-1.8966
REP.A023_A549_24H:O13,BRD-K72951360,valrubicin,A549,trt_cp,10 uM,24 h,3,576,0.7418,0.660975,1,1,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.9557,15.6536,-1.8948
REP.A023_MCF10A_24H:O14,BRD-K72951360,valrubicin,MCF10A,trt_cp,3.33 uM,24 h,3,545,0.7574,0.649668,1,1,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.9552,15.6536,-1.8939
REP.A005_A549_24H:G20,BRD-K09426783,TAS-103,A549,trt_cp,3.33 uM,24 h,3,634,0.7772,0.709809,0,0,1,1,0,Topoisomerase inhibitor,TOP1|TOP2A,-0.9541,15.6536,-1.8917
PBIOA013_MCF7_24H:O07,BRD-K37798499,etoposide,MCF7,trt_cp,10 uM,24 h,3,499,0.68,0.589027,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.9533,15.6536,-1.8902
REP.B005_A375_24H:G19,BRD-K09426783,TAS-103,A375,trt_cp,2.22 uM,24 h,3,764,0.8602,0.819742,1,1,1,1,0,Topoisomerase inhibitor,TOP1|TOP2A,-0.9523,15.6536,-1.8881
CPC006_VCAP_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,VCAP,trt_cp,1.25 uM,6 h,4,210,0.55,0.343654,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.9522,15.6536,-1.8879
REP.A023_MCF7_24H:D08,BRD-K68346641,amsacrine,MCF7,trt_cp,3.33 uM,24 h,3,495,0.7123,0.600433,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.9486,15.6536,-1.8809
REP.A015_MCF10A_24H:C13,BRD-K56334280,amonafide,MCF10A,trt_cp,10 uM,24 h,3,441,0.6898,0.557714,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.9473,15.6536,-1.8783
REP.B008_MCF10A_24H:A09,BRD-A68009927,daunorubicin,MCF10A,trt_cp,0.25 uM,24 h,2,418,0.7415,0.562956,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.9472,15.6536,-1.8781
REP.B011_A375_24H:P19,BRD-A33280134,etoposide,A375,trt_cp,2.22 uM,24 h,2,574,0.7378,0.658045,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.9453,15.6536,-1.8743
EMU001_SKMEL5_24H:C20,BRD-K21680192,mitoxantrone,SKMEL5,trt_cp,2.5 uM,24 h,2,692,0.8231,0.76315,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.9421,15.6536,-1.8679
CPC006_AGS_6H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,AGS,trt_cp,0.08 uM,6 h,2,154,0.55,0.294288,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.934,15.6536,-1.8518
CPC016_A549_24H:BRD-A35588707-001-03-0:10,BRD-A35588707,teniposide,A549,trt_cp,10 uM,24 h,3,481,0.7,0.586749,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.9328,15.6536,-1.8494
CPC006_NCIH2073_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,NCIH2073,trt_cp,1.25 uM,6 h,2,249,0.53,0.36734,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.9324,15.6536,-1.8487
EMU001_SKMEL5_24H:F09,BRD-A52530684,doxorubicin,SKMEL5,trt_cp,0.66 uM,24 h,3,723,0.8639,0.799156,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.9294,15.6536,-1.8426
CPC006_NCIH2073_6H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,NCIH2073,trt_cp,0.08 uM,6 h,2,255,0.49,0.357436,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.9248,15.6536,-1.8336
CPC006_AGS_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,AGS,trt_cp,1.25 uM,6 h,2,195,0.51,0.318884,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.921,15.6536,-1.826
REP.A020_YAPC_24H:N03,BRD-K47869605,BRD-K47869605,YAPC,trt_cp,1.11 uM,24 h,3,554,0.8186,0.68096,1,1,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.917,15.6536,-1.8182
CPC011_VCAP_6H:BRD-K37798499-001-13-2:10,BRD-K37798499,etoposide,VCAP,trt_cp,10 uM,6 h,5,212,0.34,0.27148,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.9154,15.6536,-1.815
CPC011_HA1E_6H:BRD-K37798499-001-13-2:10,BRD-K37798499,etoposide,HA1E,trt_cp,10 uM,6 h,2,173,0.38,0.259266,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.9146,15.6536,-1.8134
ASG003_U2OS_6H:F18,BRD-A71390734,idarubicin,U2OS,trt_cp,0.12 uM,6 h,5,346,0.521,0.429326,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.9111,15.6536,-1.8065
REP.B005_MCF7_24H:G21,BRD-K09426783,TAS-103,MCF7,trt_cp,0.25 uM,24 h,2,277,0.3924,0.333376,0,0,1,1,0,Topoisomerase inhibitor,TOP1|TOP2A,-0.9102,15.6536,-1.8047
CPC006_HCC515_6H:F17,BRD-A35588707,teniposide,HCC515,trt_cp,1.25 uM,6 h,3,125,0.3929,0.224092,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.9096,15.6536,-1.8035
CPC006_HEPG2_6H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,HEPG2,trt_cp,0.08 uM,6 h,3,261,0.4,0.326724,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.9087,15.6536,-1.8017
ASG003_U2OS_6H:O21,BRD-A37630846,daunorubicin,U2OS,trt_cp,0.12 uM,6 h,5,373,0.5678,0.465353,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.9066,15.6536,-1.7975
CPC015_A375_6H:BRD-K92093830-003-05-0:10,BRD-K92093830,doxorubicin,A375,trt_cp,10 uM,6 h,3,698,0.63,0.670546,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.9065,15.6536,-1.7973
REP.A023_A375_24H:D07,BRD-K68346641,amsacrine,A375,trt_cp,10 uM,24 h,3,754,0.8254,0.797716,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.9026,15.6536,-1.7896
CPC015_A549_6H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,A549,trt_cp,10 uM,6 h,2,265,0.32,0.294461,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.9014,15.6536,-1.7872
REP.A004_A375_24H:J07,BRD-K23677682,voreloxin,A375,trt_cp,10 uM,24 h,3,732,0.8275,0.786992,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PRKDC,-0.9007,15.6536,-1.7859
REP.A011_PC3_24H:P19,BRD-A33280134,etoposide,PC3,trt_cp,10 uM,24 h,3,249,0.4978,0.356006,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.9004,15.6536,-1.7853
REP.A023_JURKAT_24H:O14,BRD-K72951360,valrubicin,JURKAT,trt_cp,3.33 uM,24 h,3,168,0.2673,0.214282,0,0,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.897,15.6536,-1.7784
REP.A011_MCF7_24H:P19,BRD-A33280134,etoposide,MCF7,trt_cp,10 uM,24 h,3,456,0.5056,0.485531,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.894,15.6536,-1.7726
REP.B022_A375_24H:O16,BRD-K82135108,elesclomol,A375,trt_cp,0.08 uM,24 h,2,279,0.5339,0.390268,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.894,15.6536,-1.7724
LCP001_MCF10A.PIK3CA.HH_24H:F19,BRD-A33280134,etoposide,MCF10A,trt_cp,10 uM,24 h,3,89,0.42,0.195502,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.8935,15.6536,-1.7715
CPC013_A549_6H:BRD-K56334280-001-01-0:10,BRD-K56334280,amonafide,A549,trt_cp,10 uM,6 h,2,154,0.29,0.213693,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.8933,15.6536,-1.7712
LPROT004_YAPC_6H:BRD-K37798499:5,BRD-K37798499,etoposide,YAPC,trt_cp,4 uM,6 h,4,140,0.31,0.210657,1,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.8926,15.6536,-1.7697
CPC006_NCIH596_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,NCIH596,trt_cp,1.25 uM,6 h,2,302,0.48,0.384995,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.8923,15.6536,-1.7691
ASG003_U2OS_24H:C06,BRD-K04548931,epirubicin,U2OS,trt_cp,0.12 uM,24 h,5,273,0.5265,0.383364,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.8855,15.6536,-1.7557
REP.A023_YAPC_24H:D07,BRD-K68346641,amsacrine,YAPC,trt_cp,10 uM,24 h,3,601,0.8063,0.703908,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.8835,15.6536,-1.7518
REP.A020_HUVEC.A_24H:I19,BRD-K45152786,merbarone,HUVEC,trt_cp,10 uM,24 h,3,283,0.4384,0.356171,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8812,15.6536,-1.7472
PBIOA013_A375_24H:O10,BRD-K37798499,etoposide,A375,trt_cp,0.37 uM,24 h,3,503,0.71,0.604288,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.8793,15.6536,-1.7434
TAA001_SHSY5Y_24H:G13,BRD-K21680192,mitoxantrone,SHSY5Y,trt_cp,10 uM,24 h,3,829,0.79,0.818317,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.8771,15.6536,-1.7391
DOSVAL004_A549_24H:BRD-K21680192:10,BRD-K21680192,mitoxantrone,A549,trt_cp,10 uM,24 h,2,575,0.5294,0.5579,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.877,15.6536,-1.7388
ABY001_NCIH596_XH:BRD-K21680192:10:24,BRD-K21680192,mitoxantrone,NCIH596,trt_cp,10 uM,24 h,3,411,0.64,0.518611,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.8726,15.6536,-1.7301
AICHI002_HBL1_4H:K07,BRD-K21680192,mitoxantrone,HBL1,trt_cp,10 uM,4 h,3,346,0.42,0.385472,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.8721,15.6536,-1.7291
CPC016_HEPG2_6H:BRD-A35588707-001-03-0:10,BRD-A35588707,teniposide,HEPG2,trt_cp,10 uM,6 h,2,293,0.68,0.451356,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.8712,15.6536,-1.7274
REP.B007_HELA_24H:D01,BRD-K43797669,genistein,HELA,trt_cp,2.22 uM,24 h,2,591,0.7472,0.671959,0,0,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.8688,15.6536,-1.7225
CPC004_HT29_6H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,HT29,trt_cp,10 uM,6 h,5,537,0.7,0.619964,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.8687,15.6536,-1.7223
CPC014_VCAP_6H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,VCAP,trt_cp,10 uM,6 h,4,594,0.56,0.5832,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8675,15.6536,-1.72
PBIOA015_HA1E_24H:D09,BRD-K43389675,daunorubicin,HA1E,trt_cp,1.11 uM,24 h,3,771,0.86,0.823393,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8646,15.6536,-1.7142
REP.B008_A375_24H:A08,BRD-A68009927,daunorubicin,A375,trt_cp,0.74 uM,24 h,2,705,0.7549,0.737683,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8645,15.6536,-1.714
CPC013_VCAP_24H:BRD-K56334280-001-01-0:10,BRD-K56334280,amonafide,VCAP,trt_cp,10 uM,24 h,4,289,0.43,0.356462,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.8631,15.6536,-1.7113
CPC014_A549_24H:BRD-K07265709-003-01-5:10,BRD-K07265709,razoxane,A549,trt_cp,10 uM,24 h,3,255,0.56,0.382116,0,0,1,1,0,Chelating agent|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8601,15.6536,-1.7053
REP.B023_HUVEC.A_24H:D09,BRD-K68346641,amsacrine,HUVEC,trt_cp,0.25 uM,24 h,2,294,0.4794,0.379624,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.8597,15.6536,-1.7046
PBIOA013_PC3_24H:O07,BRD-K37798499,etoposide,PC3,trt_cp,10 uM,24 h,3,317,0.51,0.406579,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.8592,15.6536,-1.7035
CPC016_A375_6H:BRD-A35588707-001-03-0:10,BRD-A35588707,teniposide,A375,trt_cp,10 uM,6 h,4,616,0.61,0.619849,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.8572,15.6536,-1.6995
PCLB003_HA1E_24H:BRD-A52530684-003-01-7:3.33,BRD-A52530684,doxorubicin,HA1E,trt_cp,3.33 uM,24 h,3,596,0.67,0.638986,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.856,15.6536,-1.6973
REP.A004_HELA_24H:J07,BRD-K23677682,voreloxin,HELA,trt_cp,10 uM,24 h,3,400,0.5956,0.493558,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PRKDC,-0.8534,15.6536,-1.692
LJP006_PC3_24H:C22,BRD-K21680192,mitoxantrone,PC3,trt_cp,0.37 uM,24 h,3,283,0.47,0.368785,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.8532,15.6536,-1.6917
REP.A015_HT29_24H:E07,BRD-K56844688,epirubicin,HT29,trt_cp,10 uM,24 h,3,769,0.8416,0.813479,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.8514,15.6536,-1.688
DOSVAL004_HCC515_24H:BRD-K21680192:5,BRD-K21680192,mitoxantrone,HCC515,trt_cp,4 uM,24 h,3,582,0.52,0.55628,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.8513,15.6536,-1.6879
CPC014_HT29_6H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,HT29,trt_cp,10 uM,6 h,5,644,0.71,0.683758,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8491,15.6536,-1.6835
CPC014_VCAP_6H:BRD-K85985071-001-20-7:10,BRD-K85985071,ellipticine,VCAP,trt_cp,10 uM,6 h,5,284,0.37,0.327786,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.8471,15.6536,-1.6795
CPC018_HT29_6H:BRD-A52530684-001-01-1:10,BRD-A52530684,doxorubicin,HT29,trt_cp,10 uM,6 h,4,679,0.76,0.726394,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.846,15.6536,-1.6774
CPC011_VCAP_6H:BRD-K92093830-003-23-3:10,BRD-K92093830,doxorubicin,VCAP,trt_cp,10 uM,6 h,5,651,0.63,0.647577,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8455,15.6536,-1.6763
REP.A015_A375_24H:E07,BRD-K56844688,epirubicin,A375,trt_cp,10 uM,24 h,3,711,0.7605,0.743558,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.8402,15.6536,-1.6658
CPC006_H1299_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,H1299,trt_cp,1.25 uM,6 h,2,162,0.32,0.230231,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.8382,15.6536,-1.6618
AML001_CD34_24H:BRD-K43389675:0.37037,BRD-K43389675,daunorubicin,CD34,trt_cp,0.37 uM,24 h,2,580,0.76,0.671354,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8341,15.6536,-1.6537
REP.A023_YAPC_24H:O15,BRD-K72951360,valrubicin,YAPC,trt_cp,1.11 uM,24 h,3,158,0.3485,0.23728,1,1,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.8332,15.6536,-1.6519
CPC006_HCT116_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,HCT116,trt_cp,1.25 uM,6 h,2,83,0.4,0.184247,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.8315,15.6536,-1.6486
REP.A011_YAPC_24H:P19,BRD-A33280134,etoposide,YAPC,trt_cp,10 uM,24 h,3,296,0.4532,0.370358,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.8312,15.6536,-1.6481
CPC016_ASC_24H:BRD-A35588707-001-03-0:10,BRD-A35588707,teniposide,ASC,trt_cp,10 uM,24 h,3,399,0.4,0.403968,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.8301,15.6536,-1.6459
ASG003_A549_6H:O20,BRD-A37630846,daunorubicin,A549,trt_cp,1.11 uM,6 h,5,522,0.6742,0.599874,1,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.83,15.6536,-1.6456
CPC004_VCAP_6H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,VCAP,trt_cp,10 uM,6 h,3,636,0.61,0.629831,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.83,15.6536,-1.6456
CPC018_A549_6H:BRD-A52530684-001-01-1:10,BRD-A52530684,doxorubicin,A549,trt_cp,10 uM,6 h,3,478,0.67,0.572245,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8286,15.6536,-1.6429
PBIOA015_PC3_24H:D12,BRD-K43389675,daunorubicin,PC3,trt_cp,0.04 uM,24 h,3,166,0.31,0.229385,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8283,15.6536,-1.6423
CPC004_HEPG2_6H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,HEPG2,trt_cp,10 uM,6 h,3,380,0.54,0.458057,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.827,15.6536,-1.6396
REP.A005_PC3_24H:G22,BRD-K09426783,TAS-103,PC3,trt_cp,0.37 uM,24 h,2,234,0.5582,0.365455,1,1,1,1,0,Topoisomerase inhibitor,TOP1|TOP2A,-0.8268,15.6536,-1.6393
CPC006_NCIH596_6H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,NCIH596,trt_cp,0.08 uM,6 h,2,336,0.49,0.410297,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8267,15.6536,-1.6391
CPC006_PC3_24H:N01,BRD-A71390734,idarubicin,PC3,trt_cp,0.08 uM,24 h,5,273,0.426,0.344839,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8261,15.6536,-1.638
CPC014_VCAP_24H:BRD-K07265709-003-01-5:10,BRD-K07265709,razoxane,VCAP,trt_cp,10 uM,24 h,5,310,0.46,0.381848,0,0,1,1,0,Chelating agent|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8261,15.6536,-1.6379
PAC036_U2OS_6H:BRD-K21680192-300-09-4:20,BRD-K21680192,mitoxantrone,U2OS,trt_cp,20 uM,6 h,3,275,0.5,0.374957,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.8246,15.6536,-1.6349
CPC013_HEPG2_6H:BRD-K56334280-001-01-0:10,BRD-K56334280,amonafide,HEPG2,trt_cp,10 uM,6 h,3,276,0.54,0.390375,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.8245,15.6536,-1.6348
CPC003_HA1E_6H:BRD-K92093830-003-05-0:10,BRD-K92093830,doxorubicin,HA1E,trt_cp,10 uM,6 h,2,400,0.64,0.511624,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8234,15.6536,-1.6326
REP.A023_PC3_24H:O14,BRD-K72951360,valrubicin,PC3,trt_cp,3.33 uM,24 h,3,325,0.4869,0.402246,1,1,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.823,15.6536,-1.6318
REP.A015_MCF10A_24H:E08,BRD-K56844688,epirubicin,MCF10A,trt_cp,3.33 uM,24 h,3,768,0.8563,0.820019,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.8214,15.6536,-1.6286
PAC002_U2OS_6H:BRD-K43389675-003-02-7:3.54622,BRD-K43389675,daunorubicin,U2OS,trt_cp,3.33 uM,6 h,2,560,0.83,0.689388,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8214,15.6536,-1.6285
CPC004_PC3_6H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,PC3,trt_cp,10 uM,6 h,5,600,0.68,0.645893,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.8211,15.6536,-1.6281
REP.B023_PC3_24H:D08,BRD-K68346641,amsacrine,PC3,trt_cp,0.74 uM,24 h,2,217,0.361,0.283018,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.8196,15.6536,-1.6251
REP.A015_MCF7_24H:E07,BRD-K56844688,epirubicin,MCF7,trt_cp,10 uM,24 h,3,755,0.8168,0.794076,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.8173,15.6536,-1.6205
CPC016_NPC_24H:BRD-A35588707-001-03-0:10,BRD-A35588707,teniposide,NPC,trt_cp,10 uM,24 h,3,612,0.73,0.675877,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.8172,15.6536,-1.6203
REP.B022_YAPC_24H:O16,BRD-K82135108,elesclomol,YAPC,trt_cp,0.08 uM,24 h,2,150,0.2301,0.18786,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.8172,15.6536,-1.6203
DOSVAL004_A375_24H:BRD-K21680192:5,BRD-K21680192,mitoxantrone,A375,trt_cp,4 uM,24 h,3,747,0.72,0.741578,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.8165,15.6536,-1.619
CPC006_PC3_24H:F17,BRD-A35588707,teniposide,PC3,trt_cp,1.25 uM,24 h,5,289,0.4636,0.370127,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.8153,15.6536,-1.6165
CPC017_A549_24H:BRD-K43389675-001-01-3:10,BRD-K43389675,daunorubicin,A549,trt_cp,10 uM,24 h,3,719,0.78,0.757255,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8115,15.6536,-1.609
CPC017_MCF7_24H:BRD-K43389675-001-01-3:10,BRD-K43389675,daunorubicin,MCF7,trt_cp,10 uM,24 h,2,630,0.4,0.507611,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8095,15.6536,-1.6049
REP.A006_YAPC_24H:I13,BRD-K21680192,mitoxantrone,YAPC,trt_cp,10 uM,24 h,2,716,0.6815,0.70635,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.8084,15.6536,-1.6029
REP.A004_PC3_24H:J07,BRD-K23677682,voreloxin,PC3,trt_cp,10 uM,24 h,3,494,0.7392,0.611048,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PRKDC,-0.8084,15.6536,-1.6027
PCLB003_A375_24H:BRD-A52530684-003-01-7:10,BRD-A52530684,doxorubicin,A375,trt_cp,10 uM,24 h,3,695,0.72,0.715302,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8075,15.6536,-1.6011
CPC015_NPC_24H:BRD-K47869605-001-18-9:10,BRD-K47869605,BRD-K47869605,NPC,trt_cp,10 uM,24 h,4,604,0.7,0.657503,0,0,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.8047,15.6536,-1.5954
REP.A015_YAPC_24H:E11,BRD-K56844688,epirubicin,YAPC,trt_cp,0.125 uM,24 h,3,226,0.497,0.338893,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.802,15.6536,-1.5901
PCLB003_MCF7_24H:BRD-A52530684-003-01-7:10,BRD-A52530684,doxorubicin,MCF7,trt_cp,10 uM,24 h,3,579,0.67,0.629807,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.8003,15.6536,-1.5867
AML001_U937_6H:D24,BRD-K43389675,daunorubicin,U937,trt_cp,0.37 uM,6 h,2,346,0.5584,0.444469,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.8001,15.6536,-1.5863
CPC015_HEPG2_6H:BRD-K92093830-003-05-0:10,BRD-K92093830,doxorubicin,HEPG2,trt_cp,10 uM,6 h,2,302,0.53,0.40455,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7985,15.6536,-1.5833
CPC006_HCC515_6H:N01,BRD-A71390734,idarubicin,HCC515,trt_cp,0.08 uM,6 h,3,396,0.6259,0.50342,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7985,15.6536,-1.5832
CPC011_HA1E_6H:BRD-K69650333-003-11-6:10,BRD-K69650333,idarubicin,HA1E,trt_cp,10 uM,6 h,2,350,0.48,0.414462,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7981,15.6536,-1.5824
CPC015_MCF7_24H:BRD-A68009927-003-02-9:10,BRD-A68009927,daunorubicin,MCF7,trt_cp,10 uM,24 h,3,695,0.69,0.700241,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7973,15.6536,-1.5809
REP.A020_MCF10A_24H:N06,BRD-K47869605,BRD-K47869605,MCF10A,trt_cp,0.04 uM,24 h,3,512,0.6337,0.57598,0,0,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.7954,15.6536,-1.5771
LCP001_MCF10A.WT_3H:D09,BRD-K92093830,doxorubicin,MCF10A,trt_cp,1.11 uM,3 h,3,185,0.49,0.304449,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7916,15.6536,-1.5695
AICHI001_KMS34_24H:K12,BRD-K21680192,mitoxantrone,KMS34,trt_cp,0.01 uM,24 h,3,155,0.4,0.251783,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.7912,15.6536,-1.5688
CPC015_MCF7_24H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,MCF7,trt_cp,10 uM,24 h,2,531,0.63,0.584855,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.7905,15.6536,-1.5674
CPC011_PC3_24H:BRD-K69650333-003-11-6:10,BRD-K69650333,idarubicin,PC3,trt_cp,10 uM,24 h,4,734,0.76,0.755241,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7894,15.6536,-1.5652
REP.A015_PC3_24H:E07,BRD-K56844688,epirubicin,PC3,trt_cp,10 uM,24 h,3,734,0.6856,0.717322,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.7882,15.6536,-1.5628
EMU001_KMS34_24H:F11,BRD-A52530684,doxorubicin,KMS34,trt_cp,0.04 uM,24 h,2,115,0.4236,0.223181,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.787,15.6536,-1.5603
POL001_HEPG2_24H:N02,BRD-A68009927,daunorubicin,HEPG2,trt_cp,3.33 uM,24 h,3,759,0.82,0.797735,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7844,15.6536,-1.5552
ABY001_NCIH508_XH:BRD-K21680192:10:24,BRD-K21680192,mitoxantrone,NCIH508,trt_cp,10 uM,24 h,3,537,0.72,0.628759,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.7837,15.6536,-1.5539
PAC011_U2OS_6H:BRD-K43797669-001-10-6:20,BRD-K43797669,genistein,U2OS,trt_cp,20 uM,6 h,3,100,0.35,0.189175,1,1,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.7836,15.6536,-1.5537
CPC014_HCC515_6H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,HCC515,trt_cp,10 uM,6 h,3,442,0.64,0.537813,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7835,15.6536,-1.5534
CPC003_VCAP_6H:BRD-A68009927-003-02-9:10,BRD-A68009927,daunorubicin,VCAP,trt_cp,10 uM,6 h,4,418,0.45,0.438556,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7834,15.6536,-1.5533
REP.A015_JURKAT_24H:E08,BRD-K56844688,epirubicin,JURKAT,trt_cp,3.33 uM,24 h,2,711,0.7697,0.748042,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.7818,15.6536,-1.5501
KHW001_U937_6H:BRD-A37630846-001-02-2:1,BRD-A37630846,daunorubicin,U937,trt_cp,1.11 uM,6 h,6,470,0.67,0.567436,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7812,15.6536,-1.5488
PBIOA018_HCC515_24H:O07,BRD-K92093830,doxorubicin,HCC515,trt_cp,10 uM,24 h,3,739,0.71,0.732457,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7786,15.6536,-1.5437
CPC006_VCAP_24H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,VCAP,trt_cp,0.08 uM,24 h,5,365,0.53,0.444749,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7775,15.6536,-1.5416
REP.A015_HELA_24H:C13,BRD-K56334280,amonafide,HELA,trt_cp,10 uM,24 h,3,358,0.5999,0.46861,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.7765,15.6536,-1.5396
REP.A015_HEK293_24H:E07,BRD-K56844688,epirubicin,HEK293,trt_cp,10 uM,24 h,3,752,0.8278,0.797815,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.7764,15.6536,-1.5394
CPC014_A549_6H:BRD-K85985071-001-20-7:10,BRD-K85985071,ellipticine,A549,trt_cp,10 uM,6 h,3,288,0.59,0.416824,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.7762,15.6536,-1.5389
HOG002_A549_24H:BRD-A68009927-003-02-9:10,BRD-A68009927,daunorubicin,A549,trt_cp,10 uM,24 h,2,598,0.74,0.672662,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7746,15.6536,-1.5357
CPC011_HT29_6H:BRD-K69650333-003-11-6:10,BRD-K69650333,idarubicin,HT29,trt_cp,10 uM,6 h,4,522,0.42,0.473468,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7727,15.6536,-1.532
CPD002_MCF7_24H:BRD-K92093830-003-21-7:10,BRD-K92093830,doxorubicin,MCF7,trt_cp,10 uM,24 h,3,655,0.76,0.713441,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7718,15.6536,-1.5302
REP.A022_HEK293_24H:O16,BRD-K82135108,elesclomol,HEK293,trt_cp,0.37 uM,24 h,3,390,0.6135,0.494618,0,0,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.771,15.6536,-1.5286
CPC014_MCF7_6H:C06,BRD-K83794624,pirarubicin,MCF7,trt_cp,10 uM,6 h,5,611,0.6828,0.653127,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7709,15.6536,-1.5285
CPC006_AGS_6H:BRD-K82135108-001-01-9:10,BRD-K82135108,elesclomol,AGS,trt_cp,10 uM,6 h,2,185,0.46,0.294982,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.7708,15.6536,-1.5283
REP.B004_A549_24H:J07,BRD-K23677682,voreloxin,A549,trt_cp,2.22 uM,24 h,2,180,0.3302,0.246522,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PRKDC,-0.7675,15.6536,-1.5218
PAC002_U2OS_6H:BRD-K47869605-001-04-9:10,BRD-K47869605,BRD-K47869605,U2OS,trt_cp,10 uM,6 h,2,162,0.39,0.254168,0,0,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.7644,15.6536,-1.5157
PBIOA015_A375_24H:D07,BRD-K43389675,daunorubicin,A375,trt_cp,10 uM,24 h,3,780,0.73,0.763026,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.764,15.6536,-1.5148
CPC011_A549_24H:BRD-K69650333-003-11-6:10,BRD-K69650333,idarubicin,A549,trt_cp,10 uM,24 h,3,686,0.75,0.725309,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7621,15.6536,-1.511
CPC020_HT29_6H:BRD-K47869605-001-27-0:10,BRD-K47869605,BRD-K47869605,HT29,trt_cp,10 uM,6 h,4,272,0.41,0.337681,1,1,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.7588,15.6536,-1.5045
REP.B012_YAPC_24H:C01,BRD-K00494077,trovafloxacin,YAPC,trt_cp,2.22 uM,24 h,2,536,0.6878,0.613966,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.756,15.6536,-1.499
CPC014_MCF7_24H:BRD-K07265709-003-01-5:10,BRD-K07265709,razoxane,MCF7,trt_cp,10 uM,24 h,3,87,0.19,0.130007,1,0,1,1,0,Chelating agent|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7551,15.6536,-1.4971
CPC014_MCF7_6H:N16,BRD-K85985071,ellipticine,MCF7,trt_cp,10 uM,6 h,5,416,0.5029,0.462507,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.7526,15.6536,-1.4921
CPC004_HCC515_6H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,HCC515,trt_cp,10 uM,6 h,3,606,0.63,0.624794,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.7464,15.6536,-1.48
REP.A018_THP1_24H:N15,BRD-K66615216,moxifloxacin,THP1,trt_cp,1.11 uM,24 h,2,141,0.0283,0.0638754,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.7461,15.6536,-1.4793
CPC004_A375_6H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,A375,trt_cp,10 uM,6 h,3,602,0.67,0.642194,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.744,15.6536,-1.4752
CPC006_THP1_6H:N01,BRD-A71390734,idarubicin,THP1,trt_cp,0.08 uM,6 h,2,614,0.0785,0.221998,1,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7432,15.6536,-1.4736
PCLB003_PC3_24H:BRD-A52530684-003-01-7:0.04,BRD-A52530684,doxorubicin,PC3,trt_cp,0.04 uM,24 h,3,324,0.6,0.44584,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7427,15.6536,-1.4726
CPC014_HT29_6H:BRD-K85985071-001-20-7:10,BRD-K85985071,ellipticine,HT29,trt_cp,10 uM,6 h,5,358,0.5,0.427816,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.7407,15.6536,-1.4685
REP.B023_HT29_24H:O13,BRD-K72951360,valrubicin,HT29,trt_cp,2.22 uM,24 h,2,300,0.5853,0.423721,1,1,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.7405,15.6536,-1.4683
PBIOA014_HA1E_24H:C22,BRD-K21680192,mitoxantrone,HA1E,trt_cp,10 uM,24 h,2,469,0.38,0.426883,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.7396,15.6536,-1.4664
AML001_HL60_6H:BRD-K43389675:1.11111,BRD-K43389675,daunorubicin,HL60,trt_cp,1.11 uM,6 h,2,717,0.82,0.775349,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7394,15.6536,-1.4659
REP.B011_A549_24H:P19,BRD-A33280134,etoposide,A549,trt_cp,2.22 uM,24 h,2,225,0.3485,0.283154,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.7393,15.6536,-1.4658
CPC006_NOMO1_6H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,NOMO1,trt_cp,0.08 uM,6 h,2,196,0.23,0.214695,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7387,15.6536,-1.4646
REP.A015_THP1_24H:E11,BRD-K56844688,epirubicin,THP1,trt_cp,0.125 uM,24 h,2,195,0.3705,0.271795,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.7382,15.6536,-1.4636
ASG003_MCF7_24H:O20,BRD-A37630846,daunorubicin,MCF7,trt_cp,1.11 uM,24 h,4,742,0.824,0.790672,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7379,15.6536,-1.4629
REP.A015_A549_24H:E07,BRD-K56844688,epirubicin,A549,trt_cp,10 uM,24 h,3,696,0.649,0.679607,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.7362,15.6536,-1.4597
REP.B015_MDAMB231_24H:E08,BRD-K56844688,epirubicin,MDAMB231,trt_cp,0.74 uM,24 h,2,282,0.3685,0.325967,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.7351,15.6536,-1.4575
MOAR001_A375_24H:J01,BRD-K66615216,moxifloxacin,A375,trt_cp,10 uM,24 h,2,155,0.2952,0.216299,1,1,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.7349,15.6536,-1.4571
HOG003_A549_24H:BRD-A71390734-001-01-7:1.11,BRD-A71390734,idarubicin,A549,trt_cp,1.11 uM,24 h,3,726,0.74,0.741165,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7347,15.6536,-1.4567
CPC017_HEPG2_6H:BRD-K43389675-001-01-3:10,BRD-K43389675,daunorubicin,HEPG2,trt_cp,10 uM,6 h,3,585,0.63,0.613873,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7329,15.6536,-1.453
CPC011_VCAP_6H:BRD-K69650333-003-11-6:10,BRD-K69650333,idarubicin,VCAP,trt_cp,10 uM,6 h,3,555,0.67,0.616616,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7315,15.6536,-1.4504
MUC.CP007_P1A82_24H:C20,BRD-K21680192,mitoxantrone,P1A82,trt_cp,10 uM,24 h,3,765,0.81,0.795983,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.7284,15.6536,-1.4443
CPC009_HCC515_6H:BRD-A68009927-001-02-3:10,BRD-A68009927,daunorubicin,HCC515,trt_cp,10 uM,6 h,3,501,0.63,0.568093,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.7231,15.6536,-1.4337
ABY001_NCIH2073_XH:BRD-K21680192:10:24,BRD-K21680192,mitoxantrone,NCIH2073,trt_cp,10 uM,24 h,3,276,0.48,0.368049,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.7206,15.3525,-1.4287
CPC004_HA1E_6H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,HA1E,trt_cp,10 uM,6 h,3,665,0.75,0.714121,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.7204,15.3525,-1.4284
REP.A012_HELA_24H:C01,BRD-K00494077,trovafloxacin,HELA,trt_cp,10 uM,24 h,2,253,0.4642,0.346532,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.7203,15.3525,-1.4282
POL001_JURKAT_24H:C22,BRD-K21680192,mitoxantrone,JURKAT,trt_cp,0.37 uM,24 h,2,739,0.82,0.787154,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.7174,15.3525,-1.4224
CPC003_PC3_6H:BRD-K92093830-003-05-0:10,BRD-K92093830,doxorubicin,PC3,trt_cp,10 uM,6 h,4,426,0.45,0.442733,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7158,15.3525,-1.4192
REP.B022_HUVEC.A_24H:O16,BRD-K82135108,elesclomol,HUVEC,trt_cp,0.08 uM,24 h,2,206,0.0419,0.0939445,0,0,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.7148,15.3525,-1.4173
CPC013_MCF7_6H:BRD-K56334280-001-01-0:10,BRD-K56334280,amonafide,MCF7,trt_cp,10 uM,6 h,4,387,0.55,0.466517,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.7147,15.3525,-1.4171
HOG002_A549_24H:BRD-K92093830-003-18-3:10,BRD-K92093830,doxorubicin,A549,trt_cp,10 uM,24 h,2,657,0.72,0.695472,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.713,15.3525,-1.4137
GMB001_HL60_24H:BRD-K21680192:10,BRD-K21680192,mitoxantrone,HL60,trt_cp,10 uM,24 h,4,506,0.64,0.575434,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.7119,15.3525,-1.4114
CPC014_HEPG2_6H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,HEPG2,trt_cp,10 uM,6 h,3,546,0.53,0.543957,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7073,5.5802,-1.4023
CPC014_HT29_6H:BRD-K43797669-001-13-0:10,BRD-K43797669,genistein,HT29,trt_cp,10 uM,6 h,5,436,0.54,0.490649,0,0,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.7035,4.5258,-1.3948
ASG003_MCF7_6H:F16,BRD-A71390734,idarubicin,MCF7,trt_cp,12 uM,6 h,5,696,0.7855,0.747667,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.7013,4.335,-1.3905
CPC006_NCIH596_6H:BRD-K82135108-001-01-9:10,BRD-K82135108,elesclomol,NCIH596,trt_cp,10 uM,6 h,2,259,0.56,0.385101,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.6988,4.1855,-1.3856
CPC006_H1299_6H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,H1299,trt_cp,0.08 uM,6 h,2,74,0.34,0.160393,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6977,4.1308,-1.3834
REP.A015_YAPC_24H:C13,BRD-K56334280,amonafide,YAPC,trt_cp,10 uM,24 h,3,486,0.7389,0.605957,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.6968,4.089,-1.3815
CPC014_HA1E_6H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,HA1E,trt_cp,10 uM,6 h,3,393,0.63,0.50315,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6922,3.9242,-1.3724
CPC006_HCC515_6H:G18,BRD-K82135108,elesclomol,HCC515,trt_cp,10 uM,6 h,3,168,0.4482,0.277473,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.6892,3.8422,-1.3666
CPC014_PC3_24H:BRD-K07265709-003-01-5:10,BRD-K07265709,razoxane,PC3,trt_cp,10 uM,24 h,5,312,0.55,0.41888,1,1,1,1,0,Chelating agent|Topoisomerase inhibitor,TOP2A|TOP2B,-0.6881,3.8133,-1.3642
EMU001_OCILY19_24H:F11,BRD-A52530684,doxorubicin,OCILY19,trt_cp,0.04 uM,24 h,3,374,0.6735,0.507499,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6877,3.8043,-1.3635
REP.A020_HUVEC.A_24H:N01,BRD-K47869605,BRD-K47869605,HUVEC,trt_cp,10 uM,24 h,3,526,0.6622,0.596785,1,1,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.6877,3.8039,-1.3634
CVD001_HEPG2_6H:BRD-K47869605-001-18-9:10,BRD-K47869605,BRD-K47869605,HEPG2,trt_cp,10 uM,6 h,3,302,0.62,0.437552,1,1,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.6848,3.7414,-1.3578
CPC014_NPC_24H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,NPC,trt_cp,10 uM,24 h,3,713,0.76,0.744358,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6818,3.6836,-1.3518
REP.A004_HEK293_24H:N04,BRD-A24228527,ofloxacin,HEK293,trt_cp,0.37 uM,24 h,2,108,0.5945,0.256223,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.6812,3.6723,-1.3506
EMU001_BJAB_3H:C21,BRD-K21680192,mitoxantrone,BJAB,trt_cp,0.66 uM,3 h,3,324,0.5268,0.417759,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.6757,3.5855,-1.3397
ISO002_HCT116.TP53.HR_24H:K11,BRD-K21680192,mitoxantrone,HCT116,trt_cp,0.125 uM,24 h,3,171,0.5599,0.312884,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.6745,3.5687,-1.3373
CPC006_NCIH508_6H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,NCIH508,trt_cp,0.08 uM,6 h,2,114,0.47,0.234063,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6723,3.5404,-1.333
REP.A011_MDAMB231_24H:P19,BRD-A33280134,etoposide,MDAMB231,trt_cp,10 uM,24 h,3,276,0.4214,0.344852,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.6718,3.5341,-1.332
REP.A023_THP1_24H:O13,BRD-K72951360,valrubicin,THP1,trt_cp,10 uM,24 h,2,504,0.5677,0.540885,0,0,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.6715,3.5308,-1.3315
CPC014_A375_6H:C06,BRD-K83794624,pirarubicin,A375,trt_cp,10 uM,6 h,2,546,0.3706,0.454862,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6698,3.5108,-1.3279
CPC014_ASC_24H:BRD-K85985071-001-20-7:10,BRD-K85985071,ellipticine,ASC,trt_cp,10 uM,24 h,3,242,0.27,0.258476,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.6676,3.4915,-1.3237
KHW001_HA1E_6H:BRD-A37630846-001-02-2:1,BRD-A37630846,daunorubicin,HA1E,trt_cp,1.11 uM,6 h,6,430,0.55,0.491752,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.6671,3.4873,-1.3226
REP.B008_YAPC_24H:A10,BRD-A68009927,daunorubicin,YAPC,trt_cp,0.08 uM,24 h,2,163,0.3877,0.254198,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.6633,3.4618,-1.3152
PBIOA015_HCC515_24H:D07,BRD-K43389675,daunorubicin,HCC515,trt_cp,10 uM,24 h,3,773,0.6646,0.72477,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.6576,3.4187,-1.3038
CPC006_NOMO1_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,NOMO1,trt_cp,1.25 uM,6 h,2,233,0.55,0.361984,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.6557,3.4003,-1.3
CPC006_NCIH2073_6H:BRD-K82135108-001-01-9:10,BRD-K82135108,elesclomol,NCIH2073,trt_cp,10 uM,6 h,2,76,0.16,0.111506,0,0,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.6536,3.3763,-1.2958
CPC014_A375_6H:N16,BRD-K85985071,ellipticine,A375,trt_cp,10 uM,6 h,2,290,0.4267,0.355706,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.6535,3.375,-1.2956
CPC006_HCT116_6H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,HCT116,trt_cp,0.08 uM,6 h,2,94,0.05,0.0693233,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6529,3.368,-1.2945
CVD001_HUH7_6H:BRD-K21680192-300-04-5:2.5,BRD-K21680192,mitoxantrone,HUH7,trt_cp,2.5 uM,6 h,3,494,0.63,0.564111,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.6508,3.3381,-1.2902
CPC011_HA1E_6H:BRD-K09471561-001-15-8:10,BRD-K09471561,levofloxacin,HA1E,trt_cp,10 uM,6 h,2,258,0.41,0.328876,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.6506,3.3358,-1.2899
REP.A020_MCF10A_24H:I19,BRD-K45152786,merbarone,MCF10A,trt_cp,10 uM,24 h,3,244,0.3324,0.287976,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6498,3.3237,-1.2884
LIVB002_HUH7_72H:O07,BRD-K04804440,ciprofloxacin,HUH7,trt_cp,10 uM,72 h,3,138,0.13,0.135438,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.6491,3.3116,-1.2869
CPC014_A549_24H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,A549,trt_cp,10 uM,24 h,3,485,0.69,0.58496,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6472,3.2792,-1.2831
LJP007_HEK293_24H:B04,BRD-K21680192,mitoxantrone,HEK293,trt_cp,10 uM,24 h,2,710,0.8293,0.775918,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.6446,3.1281,-1.278
CPC013_HCC515_6H:BRD-K56334280-001-01-0:10,BRD-K56334280,amonafide,HCC515,trt_cp,10 uM,6 h,2,107,0.38,0.203899,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.6427,3.0818,-1.2743
MOAR003_A375_24H:I23,BRD-K47869605,BRD-K47869605,A375,trt_cp,3.33 uM,24 h,3,518,0.79,0.646858,1,1,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.6424,3.0769,-1.2736
REP.A026_YAPC_24H:L24,BRD-K92093830,doxorubicin,YAPC,trt_cp,0.04 uM,24 h,2,221,0.3997,0.300534,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6368,2.9435,-1.2625
REP.A026_HUVEC.A_24H:L19,BRD-K92093830,doxorubicin,HUVEC,trt_cp,10 uM,24 h,2,678,0.7397,0.716099,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6339,2.8755,-1.2568
REP.A023_JURKAT_24H:D10,BRD-K68346641,amsacrine,JURKAT,trt_cp,0.37 uM,24 h,3,246,0.3757,0.307411,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.6338,2.8745,-1.2565
REP.A004_YAPC_24H:P09,BRD-A26423207,sparfloxacin,YAPC,trt_cp,1.11 uM,24 h,3,185,0.3084,0.241531,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.6337,2.8742,-1.2564
REP.A012_JURKAT_24H:C01,BRD-K00494077,trovafloxacin,JURKAT,trt_cp,10 uM,24 h,3,336,0.4747,0.40384,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.6312,2.8611,-1.2515
CPD003_MCF7_6H:BRD-K07612980-001-01-2:10,BRD-K07612980,sparfloxacin,MCF7,trt_cp,10 uM,6 h,2,164,0.25,0.204749,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.6304,2.8527,-1.2498
LJP008_NPC.TAK_24H:B04,BRD-K21680192,mitoxantrone,NPC,trt_cp,10 uM,24 h,2,739,0.7766,0.76604,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.6284,2.7997,-1.2459
CPC013_HT29_6H:A19,BRD-K56334280,amonafide,HT29,trt_cp,10 uM,6 h,5,364,0.4044,0.38796,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.6272,2.7664,-1.2435
CPC011_MCF7_24H:BRD-K69650333-003-11-6:10,BRD-K69650333,idarubicin,MCF7,trt_cp,10 uM,24 h,2,490,0.63,0.561822,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6251,2.734,-1.2394
CPC014_HCC515_6H:BRD-K85985071-001-20-7:10,BRD-K85985071,ellipticine,HCC515,trt_cp,10 uM,6 h,3,250,0.36,0.303355,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.6233,2.7034,-1.2358
REP.A023_THP1_24H:D08,BRD-K68346641,amsacrine,THP1,trt_cp,3.33 uM,24 h,2,619,0.6613,0.646957,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.6227,2.6931,-1.2347
CPC006_THP1_6H:F17,BRD-A35588707,teniposide,THP1,trt_cp,1.25 uM,6 h,2,398,0.5828,0.487003,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.6219,2.6764,-1.2331
REP.A015_PC3_24H:C13,BRD-K56334280,amonafide,PC3,trt_cp,10 uM,24 h,3,325,0.544,0.425179,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.6212,2.6557,-1.2317
EMU001_HBL1_24H:F10,BRD-A52530684,doxorubicin,HBL1,trt_cp,0.125 uM,24 h,3,362,0.7322,0.520595,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6205,2.6383,-1.2302
EMU001_BJAB_6H:F07,BRD-A52530684,doxorubicin,BJAB,trt_cp,10 uM,6 h,3,709,0.7726,0.748395,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6154,2.6002,-1.2201
REP.B008_HEK293_24H:A08,BRD-A68009927,daunorubicin,HEK293,trt_cp,0.74 uM,24 h,2,503,0.6964,0.598472,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.6115,2.5218,-1.2124
REP.B020_HEK293_24H:N06,BRD-K47869605,BRD-K47869605,HEK293,trt_cp,0.01 uM,24 h,2,191,0.3976,0.278657,0,0,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.6112,2.5156,-1.2118
CPC006_U937_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,U937,trt_cp,1.25 uM,6 h,2,433,0.76,0.580071,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.6111,2.5121,-1.2116
REP.A004_PC3_24H:P11,BRD-A26423207,sparfloxacin,PC3,trt_cp,0.125 uM,24 h,3,150,0.3249,0.223229,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.6099,2.47,-1.2092
CPC006_U937_6H:BRD-A71390734-001-01-7:0.08,BRD-A71390734,idarubicin,U937,trt_cp,0.08 uM,6 h,2,280,0.28,0.283132,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.6078,2.4317,-1.2052
CPC014_ASC_24H:BRD-K07265709-003-01-5:10,BRD-K07265709,razoxane,ASC,trt_cp,10 uM,24 h,3,175,0.33,0.243,1,1,1,1,0,Chelating agent|Topoisomerase inhibitor,TOP2A|TOP2B,-0.6031,2.3317,-1.1957
REP.B005_YAPC_24H:G22,BRD-K09426783,TAS-103,YAPC,trt_cp,0.08 uM,24 h,2,164,0.3099,0.227962,0,0,1,1,0,Topoisomerase inhibitor,TOP1|TOP2A,-0.6022,2.3238,-1.1939
CPC013_HA1E_6H:BRD-K56334280-001-01-0:10,BRD-K56334280,amonafide,HA1E,trt_cp,10 uM,6 h,3,149,0.38,0.240611,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.598,2.2065,-1.1856
REP.B022_HELA_24H:O13,BRD-K82135108,elesclomol,HELA,trt_cp,2.22 uM,24 h,2,93,0.4192,0.199656,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.5973,2.1978,-1.1843
CPC014_HA1E_6H:BRD-K85985071-001-20-7:10,BRD-K85985071,ellipticine,HA1E,trt_cp,10 uM,6 h,3,246,0.45,0.336437,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.5942,2.1851,-1.1781
CPC011_PC3_24H:BRD-K55034111-066-12-2:10,BRD-K55034111,pefloxacin,PC3,trt_cp,10 uM,24 h,4,333,0.08,0.165043,1,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.5937,2.1834,-1.1771
REP.A023_HELA_24H:O15,BRD-K72951360,valrubicin,HELA,trt_cp,1.11 uM,24 h,3,145,0.3554,0.229548,1,1,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.5935,2.1819,-1.1767
ERG005_VCAP_6H:BRD-K21680192-300-08-6:5,BRD-K21680192,mitoxantrone,VCAP,trt_cp,4 uM,6 h,3,704,0.87,0.791364,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.5909,2.1386,-1.1716
REP.A022_A549_24H:O13,BRD-K82135108,elesclomol,A549,trt_cp,10 uM,24 h,3,198,0.3129,0.25169,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.5886,2.1311,-1.167
REP.B007_YAPC_24H:D01,BRD-K43797669,genistein,YAPC,trt_cp,2.22 uM,24 h,2,509,0.7222,0.613081,1,1,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.5863,2.1032,-1.1625
EMU001_TMD8_6H:F07,BRD-A52530684,doxorubicin,TMD8,trt_cp,10 uM,6 h,3,660,0.7636,0.717853,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.5856,2.0963,-1.1611
CPC016_SKB_24H:BRD-A35588707-001-03-0:10,BRD-A35588707,teniposide,SKB,trt_cp,10 uM,24 h,3,344,0.6,0.459394,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.5826,2.0295,-1.1551
REP.B026_HELA_24H:L22,BRD-K92093830,doxorubicin,HELA,trt_cp,0.08 uM,24 h,2,150,0.3175,0.220672,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.5826,2.0296,-1.1551
REP.B020_MCF7_24H:N03,BRD-K47869605,BRD-K47869605,MCF7,trt_cp,0.25 uM,24 h,2,482,0.7931,0.625199,1,1,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.5797,1.9787,-1.1493
PCLB003_A549_24H:BRD-K43797669-001-21-3:10,BRD-K43797669,genistein,A549,trt_cp,10 uM,24 h,3,172,0.25,0.209684,1,1,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.5791,1.9697,-1.1483
REP.B022_HA1E_24H:O17,BRD-K82135108,elesclomol,HA1E,trt_cp,0.03 uM,24 h,2,166,0.3218,0.23371,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.5775,1.9622,-1.1451
REP.A023_HEK293_24H:O14,BRD-K72951360,valrubicin,HEK293,trt_cp,3.33 uM,24 h,3,489,0.7358,0.606548,1,1,1,1,0,DNA inhibitor|Topoisomerase inhibitor,TOP2A,-0.5769,1.9582,-1.1438
REP.B020_A549_24H:N02,BRD-K47869605,BRD-K47869605,A549,trt_cp,0.74 uM,24 h,2,356,0.5656,0.453743,0,0,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.5744,1.9364,-1.1388
REP.A012_MDAMB231_24H:C05,BRD-K00494077,trovafloxacin,MDAMB231,trt_cp,0.125 uM,24 h,2,83,0.0368,0.0558848,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.5736,1.9316,-1.1373
CPC006_SW480_6H:BRD-K82135108-001-01-9:10,BRD-K82135108,elesclomol,SW480,trt_cp,10 uM,6 h,2,149,0.27,0.202818,0,0,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.5681,1.8922,-1.1263
CPC014_PC3_24H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,PC3,trt_cp,10 uM,24 h,5,616,0.67,0.649618,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.5624,1.8371,-1.1151
REP.B011_HUVEC.A_24H:C14,BRD-K04804440,ciprofloxacin,HUVEC,trt_cp,0.74 uM,24 h,2,60,0.0641,0.0627098,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.562,1.835,-1.1142
REP.B007_A375_24H:D01,BRD-K43797669,genistein,A375,trt_cp,2.22 uM,24 h,2,111,0.2813,0.17868,1,1,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.5618,1.834,-1.114
LJP005_HS578T_3H:C24,BRD-K21680192,mitoxantrone,HS578T,trt_cp,0.04 uM,3 h,2,76,0.2741,0.145946,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.5601,1.8057,-1.1105
AICHI002_TMD8_24H:K11,BRD-K21680192,mitoxantrone,TMD8,trt_cp,0.04 uM,24 h,3,373,0.63,0.49018,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.5593,1.7993,-1.109
REP.A022_MDAMB231_24H:O14,BRD-K82135108,elesclomol,MDAMB231,trt_cp,3.33 uM,24 h,3,168,0.0539,0.0962232,0,0,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.5584,1.7675,-1.1071
RAD001_A549_6H:BRD-K32107296-001-04-5:0.0137,BRD-K32107296,temozolomide,A549,trt_cp,0.01 uM,6 h,3,167,0.29,0.22253,0,0,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.5567,1.7551,-1.1037
REP.B009_HT29_24H:K02,BRD-K32107296,temozolomide,HT29,trt_cp,0.74 uM,24 h,2,150,0.5229,0.283195,0,0,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.5563,1.7472,-1.103
REP.B024_A549_24H:L19,BRD-K78113049,enoxacin,A549,trt_cp,2.22 uM,24 h,2,115,0.2689,0.177818,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.5515,1.6956,-1.0935
REP.B008_HT29_24H:A10,BRD-A68009927,daunorubicin,HT29,trt_cp,0.08 uM,24 h,2,179,0.4023,0.271351,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.5466,1.6522,-1.0838
LJP006_HME1_3H:C22,BRD-K21680192,mitoxantrone,HME1,trt_cp,0.37 uM,3 h,3,208,0.52,0.332555,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.5464,1.647,-1.0833
PBIOA013_HT29_24H:O07,BRD-K37798499,etoposide,HT29,trt_cp,10 uM,24 h,3,262,0.31,0.288179,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.544,1.6072,-1.0786
REP.B024_THP1_24H:L22,BRD-K78113049,enoxacin,THP1,trt_cp,0.08 uM,24 h,2,105,0.1482,0.126139,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.5387,1.5339,-1.0681
CPD001_MCF7_6H:P17,BRD-A75850590,lomefloxacin,MCF7,trt_cp,10 uM,6 h,3,177,0.2071,0.193601,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.5385,1.5333,-1.0678
RAD001_HCC515_6H:BRD-K32107296-001-04-5:0.0015,BRD-K32107296,temozolomide,HCC515,trt_cp,0.002 uM,6 h,3,129,0.18,0.154085,0,0,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.5384,1.5281,-1.0674
LPROT005_MCF10A_6H:BRD-K37798499:0.316,BRD-K37798499,etoposide,MCF10A,trt_cp,0.3 uM,6 h,3,86,0.24,0.145273,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.5359,1.5095,-1.0626
LJP005_MCF7_3H:C19,BRD-K21680192,mitoxantrone,MCF7,trt_cp,10 uM,3 h,2,184,0.4539,0.292226,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.5343,1.503,-1.0593
LJP005_SKBR3_3H:C22,BRD-K21680192,mitoxantrone,SKBR3,trt_cp,0.37 uM,3 h,2,148,0.3467,0.229054,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.534,1.5022,-1.0588
LJP009_HUVEC_24H:B04,BRD-K21680192,mitoxantrone,HUVEC,trt_cp,10 uM,24 h,3,748,0.751,0.757882,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.5327,1.4846,-1.0562
CPC014_PC3_6H:BRD-K85985071-001-20-7:10,BRD-K85985071,ellipticine,PC3,trt_cp,10 uM,6 h,4,319,0.57,0.431185,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.529,1.4498,-1.0489
NMH002_NEU_6H:BRD-K32107296-001-11-0:10,BRD-K32107296,temozolomide,NEU,trt_cp,10 uM,6 h,3,299,0.45,0.370913,0,0,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.527,1.4425,-1.0449
LJP005_MDAMB231_24H:C24,BRD-K21680192,mitoxantrone,MDAMB231,trt_cp,0.04 uM,24 h,2,256,0.5008,0.362062,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.5248,1.4115,-1.0405
CPC014_SKB_24H:BRD-K07265709-003-01-5:10,BRD-K07265709,razoxane,SKB,trt_cp,10 uM,24 h,4,62,0.16,0.100713,0,0,1,1,0,Chelating agent|Topoisomerase inhibitor,TOP2A|TOP2B,-0.5241,1.407,-1.0392
CPC006_HEPG2_6H:BRD-K82135108-001-01-9:10,BRD-K82135108,elesclomol,HEPG2,trt_cp,10 uM,6 h,3,177,0.04,0.0850839,1,0,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.522,1.3965,-1.035
CPC014_VCAP_6H:BRD-K66615216-001-01-9:10,BRD-K66615216,moxifloxacin,VCAP,trt_cp,10 uM,6 h,5,311,0.33,0.323942,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.5133,1.3199,-1.0178
REP.A024_MCF10A_24H:L19,BRD-K78113049,enoxacin,MCF10A,trt_cp,10 uM,24 h,3,135,0.3951,0.233534,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.5069,1.2566,-1.0051
PCLB003_HCC515_24H:BRD-A52530684-003-01-7:0.12,BRD-A52530684,doxorubicin,HCC515,trt_cp,0.12 uM,24 h,3,410,0.59,0.497334,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.5055,1.2468,-1.0023
DOS009_VCAP_24H:BRD-K43797669:10,BRD-K43797669,genistein,VCAP,trt_cp,10 uM,24 h,3,113,0.29,0.18305,1,1,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.5039,1.2407,-0.9991
CPD003_MCF7_6H:BRD-K78113049-001-10-5:10,BRD-K78113049,enoxacin,MCF7,trt_cp,10 uM,6 h,2,169,0.26,0.211963,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.5029,1.2305,-0.9971
CPC006_SW480_6H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,SW480,trt_cp,1.25 uM,6 h,2,175,0.1,0.133767,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.5017,1.2249,-0.9947
REP.A026_HEK293_24H:L22,BRD-K92093830,doxorubicin,HEK293,trt_cp,0.37 uM,24 h,2,428,0.2794,0.349676,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.5001,1.2173,-0.9916
CPC014_HEPG2_6H:BRD-K66615216-001-01-9:10,BRD-K66615216,moxifloxacin,HEPG2,trt_cp,10 uM,6 h,3,78,0.15,0.109376,1,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4958,1.178,-0.9829
REP.A018_YAPC_24H:N13,BRD-K66615216,moxifloxacin,YAPC,trt_cp,10 uM,24 h,3,100,0.2106,0.146744,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.493,1.1565,-0.9775
REP.A012_MCF7_24H:C01,BRD-K00494077,trovafloxacin,MCF7,trt_cp,10 uM,24 h,3,285,0.4583,0.36545,1,1,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4892,1.1239,-0.97
REP.B004_PC3_24H:N04,BRD-A24228527,ofloxacin,PC3,trt_cp,0.08 uM,24 h,3,70,0.234,0.129416,1,1,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4885,1.1186,-0.9685
LIVB002_HUH7_72H:F03,BRD-K11196887,norfloxacin,HUH7,trt_cp,10 uM,72 h,2,579,0.28,0.407145,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.4884,1.1185,-0.9684
REP.B018_MDAMB231_24H:N16,BRD-K66615216,moxifloxacin,MDAMB231,trt_cp,0.08 uM,24 h,2,98,0.0658,0.0812001,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4879,1.115,-0.9674
PBIOA013_HEPG2_24H:O08,BRD-K37798499,etoposide,HEPG2,trt_cp,3.33 uM,24 h,3,361,0.6,0.470609,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.487,1.1095,-0.9656
REP.A024_HA1E_24H:L24,BRD-K78113049,enoxacin,HA1E,trt_cp,0.04 uM,24 h,3,171,0.3334,0.241441,1,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.4854,1.0954,-0.9625
REP.B018_JURKAT_24H:N18,BRD-K66615216,moxifloxacin,JURKAT,trt_cp,0.01 uM,24 h,2,114,0.1107,0.113594,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4824,1.0693,-0.9564
CPC006_U937_6H:BRD-K32107296-001-03-7:10,BRD-K32107296,temozolomide,U937,trt_cp,10 uM,6 h,2,77,0.06,0.0687308,1,0,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.4785,1.0353,-0.9488
REP.A020_PC3_24H:N02,BRD-K47869605,BRD-K47869605,PC3,trt_cp,3.33 uM,24 h,3,452,0.652,0.548938,1,1,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.4784,1.0336,-0.9485
CPC011_A375_6H:BRD-K69650333-003-11-6:10,BRD-K69650333,idarubicin,A375,trt_cp,10 uM,6 h,3,489,0.54,0.519615,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.4776,1.0273,-0.9469
EMU001_OCILY3_24H:F10,BRD-A52530684,doxorubicin,OCILY3,trt_cp,0.125 uM,24 h,3,390,0.6681,0.516159,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.4764,1.0156,-0.9446
REP.B022_PC3_24H:O18,BRD-K82135108,elesclomol,PC3,trt_cp,0.01 uM,24 h,2,94,0.3014,0.170203,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.4708,0.9771,-0.9334
REP.B005_A375_24H:O08,BRD-K11196887,norfloxacin,A375,trt_cp,0.74 uM,24 h,3,69,0.1676,0.108741,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.4703,0.9735,-0.9325
REP.A011_HEK293_24H:C17,BRD-K04804440,ciprofloxacin,HEK293,trt_cp,0.125 uM,24 h,2,142,0.1462,0.145696,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.4677,0.9527,-0.9274
ASG003_A549_24H:E01,BRD-K66615216,moxifloxacin,A549,trt_cp,10 uM,24 h,5,199,0.3888,0.281268,1,1,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4636,0.9244,-0.9191
CPC006_NCIH596_6H:BRD-K32107296-001-03-7:10,BRD-K32107296,temozolomide,NCIH596,trt_cp,10 uM,6 h,2,147,0.09,0.116308,0,0,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.4633,0.9237,-0.9187
CPC014_ASC_24H:BRD-K66615216-001-01-9:10,BRD-K66615216,moxifloxacin,ASC,trt_cp,10 uM,24 h,3,145,0.22,0.180603,1,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4591,0.8912,-0.9102
REP.B011_HT29_24H:C15,BRD-K04804440,ciprofloxacin,HT29,trt_cp,0.25 uM,24 h,2,67,0.0376,0.050753,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.4546,0.8616,-0.9013
EMU001_MINO_24H:C23,BRD-K21680192,mitoxantrone,MINO,trt_cp,0.04 uM,24 h,3,237,0.4926,0.345503,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.4519,0.8481,-0.896
CPC006_HT29_24H:BRD-A35588707-001-03-0:1.25,BRD-A35588707,teniposide,HT29,trt_cp,1.25 uM,24 h,4,266,0.51,0.37244,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.4516,0.8472,-0.8954
REP.B012_HUVEC.A_24H:C01,BRD-K00494077,trovafloxacin,HUVEC,trt_cp,2.22 uM,24 h,2,162,0.0968,0.126627,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4512,0.8451,-0.8946
REP.A020_MDAMB231_24H:N01,BRD-K47869605,BRD-K47869605,MDAMB231,trt_cp,10 uM,24 h,2,338,0.5774,0.446712,1,1,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.447,0.8259,-0.8863
REP.B004_HELA_24H:N01,BRD-A24228527,ofloxacin,HELA,trt_cp,2.22 uM,24 h,3,133,0.2159,0.171349,1,1,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4436,0.8023,-0.8795
CRCGN015_HEPG2_48H:BRD-K68346641:97.1457,BRD-K68346641,amsacrine,HEPG2,trt_cp,100 uM,48 h,3,774,0.82,0.805579,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.4427,0.7962,-0.8778
REP.B008_JURKAT_24H:A07,BRD-A68009927,daunorubicin,JURKAT,trt_cp,2.22 uM,24 h,2,795,0.777,0.794739,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.441,0.7864,-0.8744
LJP005_HT29_24H:C23,BRD-K21680192,mitoxantrone,HT29,trt_cp,0.12 uM,24 h,3,192,0.52,0.319509,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.4398,0.778,-0.8719
REP.B004_A549_24H:P08,BRD-A26423207,sparfloxacin,A549,trt_cp,0.74 uM,24 h,2,126,0.226,0.170636,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.4317,0.735,-0.8559
LRS001_PHH.MGH_24H:H16,BRD-A35588707,teniposide,PHH,trt_cp,10 uM,24 h,3,127,0.39,0.225043,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CYP3A5|TOP2B,-0.4306,0.7294,-0.8538
REP.B008_THP1_24H:A10,BRD-A68009927,daunorubicin,THP1,trt_cp,0.08 uM,24 h,2,165,0.5017,0.290934,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.4279,0.714,-0.8484
LJP005_BT20_3H:C20,BRD-K21680192,mitoxantrone,BT20,trt_cp,3.33 uM,3 h,3,194,0.4935,0.312878,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.4253,0.698,-0.8433
EMU001_NALM6_24H:F12,BRD-A52530684,doxorubicin,NALM6,trt_cp,0.01 uM,24 h,3,129,0.3577,0.217213,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.425,0.6947,-0.8427
REP.A007_HA1E_24H:D01,BRD-K43797669,genistein,HA1E,trt_cp,10 uM,24 h,3,291,0.5581,0.407505,1,1,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.4247,0.6919,-0.842
ASG003_U2OS_24H:I10,BRD-K32107296,temozolomide,U2OS,trt_cp,10 uM,24 h,4,64,0.1062,0.0833648,1,0,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.4245,0.6908,-0.8416
REP.B011_HT29_24H:P23,BRD-A33280134,etoposide,HT29,trt_cp,0.03 uM,24 h,2,82,0.1838,0.12414,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.4242,0.6885,-0.841
REP.A012_A549_24H:C01,BRD-K00494077,trovafloxacin,A549,trt_cp,10 uM,24 h,3,319,0.4748,0.393533,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4234,0.6843,-0.8395
REP.A020_MDAMB231_24H:I24,BRD-K45152786,merbarone,MDAMB231,trt_cp,0.04 uM,24 h,2,157,0.3201,0.226685,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.4227,0.6804,-0.838
LIVB002_HUH7_72H:N19,BRD-K07612980,sparfloxacin,HUH7,trt_cp,8 uM,72 h,3,82,0.11,0.096036,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.421,0.6696,-0.8348
REP.B012_PC3_24H:C01,BRD-K00494077,trovafloxacin,PC3,trt_cp,2.22 uM,24 h,2,140,0.4464,0.252788,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4168,0.6443,-0.8264
RAD001_PC3_6H:BRD-K32107296-001-04-5:0.0137,BRD-K32107296,temozolomide,PC3,trt_cp,0.01 uM,6 h,2,176,0.23,0.203447,0,0,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.4154,0.6361,-0.8236
REP.A012_HA1E_24H:C01,BRD-K00494077,trovafloxacin,HA1E,trt_cp,10 uM,24 h,3,464,0.661,0.560003,1,1,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4147,0.6332,-0.8222
REP.B004_HT29_24H:P11,BRD-A26423207,sparfloxacin,HT29,trt_cp,0.03 uM,24 h,2,117,0.1335,0.126376,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.4124,0.6223,-0.8176
PCLB003_HEPG2_24H:BRD-A52530684-003-01-7:3.33,BRD-A52530684,doxorubicin,HEPG2,trt_cp,3.33 uM,24 h,3,575,0.77,0.672837,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.4117,0.6192,-0.8162
REP.B005_HT29_24H:G19,BRD-K09426783,TAS-103,HT29,trt_cp,2.22 uM,24 h,2,252,0.4228,0.330064,0,0,1,1,0,Topoisomerase inhibitor,TOP1|TOP2A,-0.4095,0.6084,-0.8119
REP.A011_HEK293_24H:P21,BRD-A33280134,etoposide,HEK293,trt_cp,1.11 uM,24 h,2,145,0.1875,0.166731,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.4089,0.6056,-0.8108
CPC014_NPC_24H:BRD-K66615216-001-01-9:10,BRD-K66615216,moxifloxacin,NPC,trt_cp,10 uM,24 h,3,154,0.19,0.172969,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.4089,0.6053,-0.8107
CPC014_SKB_24H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,SKB,trt_cp,10 uM,24 h,2,215,0.15,0.181591,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.4085,0.6023,-0.81
REP.A015_THP1_24H:C13,BRD-K56334280,amonafide,THP1,trt_cp,10 uM,24 h,2,504,0.454,0.483697,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.4066,0.5933,-0.8063
PBIOA013_HCC515_24H:O07,BRD-K37798499,etoposide,HCC515,trt_cp,10 uM,24 h,3,478,0.74,0.601396,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B|CYP2E1|CYP3A5,-0.4067,0.5933,-0.8063
CPC014_PHH_24H:BRD-K07265709-003-01-5:10,BRD-K07265709,razoxane,PHH,trt_cp,10 uM,24 h,4,233,0.22,0.228939,0,0,1,1,0,Chelating agent|Topoisomerase inhibitor,TOP2A|TOP2B,-0.4033,0.576,-0.7997
PBIOA015_HT29_24H:D09,BRD-K43389675,daunorubicin,HT29,trt_cp,1.11 uM,24 h,3,649,0.8,0.728615,1,1,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.3985,0.5507,-0.7901
PAC004_U2OS_6H:BRD-K11196887-001-04-8:10,BRD-K11196887,norfloxacin,U2OS,trt_cp,10 uM,6 h,2,18,0.28,0.071787,1,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.3983,0.5492,-0.7897
REP.B024_A375_24H:L24,BRD-K78113049,enoxacin,A375,trt_cp,0.01 uM,24 h,2,105,0.1863,0.141427,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.3955,0.5351,-0.7841
CPC014_NPC_24H:BRD-K85985071-001-20-7:10,BRD-K85985071,ellipticine,NPC,trt_cp,10 uM,24 h,3,157,0.23,0.192152,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|TOP2B,-0.3952,0.5331,-0.7836
CPC014_NPC_24H:BRD-K07265709-003-01-5:10,BRD-K07265709,razoxane,NPC,trt_cp,10 uM,24 h,3,113,0.19,0.148165,0,0,1,1,0,Chelating agent|Topoisomerase inhibitor,TOP2A|TOP2B,-0.3888,0.5032,-0.7709
CPC011_HT29_6H:BRD-K55034111-066-12-2:10,BRD-K55034111,pefloxacin,HT29,trt_cp,10 uM,6 h,4,139,0.06,0.092345,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.3852,0.4861,-0.7638
CVD001_PHH_24H:BRD-K47869605-001-18-9:10,BRD-K47869605,BRD-K47869605,PHH,trt_cp,10 uM,24 h,3,153,0.33,0.227213,0,0,1,1,0,Tubulin inhibitor,IGF1R|TOP2A|TUBA4A|TUBB,-0.3827,0.4731,-0.7587
REP.A020_YAPC_24H:I19,BRD-K45152786,merbarone,YAPC,trt_cp,10 uM,24 h,3,169,0.1691,0.170941,1,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.3811,0.4678,-0.7556
REP.B020_MCF7_24H:I22,BRD-K45152786,merbarone,MCF7,trt_cp,0.08 uM,24 h,2,52,0.1024,0.0737874,1,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.381,0.4676,-0.7554
CPC006_H1299_6H:BRD-K82135108-001-01-9:10,BRD-K82135108,elesclomol,H1299,trt_cp,10 uM,6 h,2,80,0.08,0.0808948,0,0,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.3748,0.4377,-0.7432
REP.A004_MCF7_24H:N01,BRD-A24228527,ofloxacin,MCF7,trt_cp,10 uM,24 h,3,145,0.1585,0.153295,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.3742,0.4344,-0.7419
REP.A005_YAPC_24H:H24,BRD-K09471561,levofloxacin,YAPC,trt_cp,0.04 uM,24 h,3,363,0.5013,0.431353,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.3718,0.4237,-0.7373
REP.A004_HEK293_24H:P08,BRD-A26423207,sparfloxacin,HEK293,trt_cp,3.33 uM,24 h,3,201,0.4102,0.290353,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.3631,0.3886,-0.72
CPC015_ASC_24H:BRD-A68009927-003-02-9:10,BRD-A68009927,daunorubicin,ASC,trt_cp,10 uM,24 h,4,660,0.73,0.701882,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.3622,0.3843,-0.7182
REP.B007_MCF7_24H:D01,BRD-K43797669,genistein,MCF7,trt_cp,2.22 uM,24 h,2,446,0.6344,0.537873,0,0,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.361,0.3798,-0.7158
REP.A011_HELA_24H:C13,BRD-K04804440,ciprofloxacin,HELA,trt_cp,10 uM,24 h,3,153,0.3874,0.246182,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.36,0.3767,-0.7137
REP.B004_HELA_24H:P12,BRD-A26423207,sparfloxacin,HELA,trt_cp,0.01 uM,24 h,3,62,0.139,0.0938715,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.3578,0.3686,-0.7093
REP.B009_HA1E_24H:K01,BRD-K32107296,temozolomide,HA1E,trt_cp,2.22 uM,24 h,2,99,0.2039,0.143667,1,1,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.357,0.3655,-0.7078
REP.B020_HT29_24H:I24,BRD-K45152786,merbarone,HT29,trt_cp,0.01 uM,24 h,2,79,0.2378,0.138596,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.3565,0.3635,-0.7068
REP.B018_HEK293_24H:N13,BRD-K66615216,moxifloxacin,HEK293,trt_cp,2.22 uM,24 h,2,70,0.0611,0.0661303,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.3532,0.3514,-0.7002
AICHI002_THP1_24H:K12,BRD-K21680192,mitoxantrone,THP1,trt_cp,0.01 uM,24 h,3,182,0.4757,0.297531,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|PIM1,-0.3444,0.3181,-0.6829
REP.B004_HT29_24H:J11,BRD-K23677682,voreloxin,HT29,trt_cp,0.03 uM,24 h,2,204,0.1976,0.20302,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|PRKDC,-0.343,0.3127,-0.6801
REP.B023_HA1E_24H:D10,BRD-K68346641,amsacrine,HA1E,trt_cp,0.08 uM,24 h,2,264,0.4612,0.352839,1,1,1,1,0,Topoisomerase inhibitor,TOP2A|KCNH2,-0.3419,0.31,-0.6779
REP.A022_HT29_24H:O14,BRD-K82135108,elesclomol,HT29,trt_cp,3.33 uM,24 h,3,201,0.4243,0.295301,1,1,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.3376,0.2962,-0.6693
EMU001_THP1_24H:F11,BRD-A52530684,doxorubicin,THP1,trt_cp,0.04 uM,24 h,3,128,0.3763,0.221923,1,1,1,1,0,Topoisomerase inhibitor,TOP2A,-0.3329,0.2803,-0.66
REP.A004_HT29_24H:N04,BRD-A24228527,ofloxacin,HT29,trt_cp,0.37 uM,24 h,3,572,0.1753,0.320199,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.3322,0.2772,-0.6587
REP.A005_MCF7_24H:H23,BRD-K09471561,levofloxacin,MCF7,trt_cp,0.125 uM,24 h,3,205,0.2093,0.209456,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.3278,0.2624,-0.6499
REP.A004_A375_24H:P07,BRD-A26423207,sparfloxacin,A375,trt_cp,10 uM,24 h,3,128,0.2058,0.164119,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.3237,0.2503,-0.6418
CPC014_NEU_24H:BRD-K07265709-003-01-5:10,BRD-K07265709,razoxane,NEU,trt_cp,10 uM,24 h,2,129,0.25,0.181591,0,0,1,1,0,Chelating agent|Topoisomerase inhibitor,TOP2A|TOP2B,-0.3214,0.2419,-0.6372
CPC018_ASC_24H:BRD-A52530684-001-01-1:10,BRD-A52530684,doxorubicin,ASC,trt_cp,10 uM,24 h,3,581,0.73,0.658537,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.3181,0.2316,-0.6306
REP.B020_A549_24H:I19,BRD-K45152786,merbarone,A549,trt_cp,2.22 uM,24 h,2,222,0.0366,0.0911481,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.3176,0.23,-0.6298
CPC014_SKB_24H:BRD-K43797669-001-13-0:10,BRD-K43797669,genistein,SKB,trt_cp,10 uM,24 h,4,315,0.37,0.345213,0,0,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.3147,0.2203,-0.624
CPC014_ASC_24H:BRD-K43797669-001-13-0:10,BRD-K43797669,genistein,ASC,trt_cp,10 uM,24 h,3,133,0.18,0.156456,1,0,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.3102,0.209,-0.6151
REP.B012_A375_24H:C01,BRD-K00494077,trovafloxacin,A375,trt_cp,2.22 uM,24 h,2,141,0.3116,0.211953,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.3081,0.2031,-0.6108
REP.B005_HT29_24H:H24,BRD-K09471561,levofloxacin,HT29,trt_cp,0.01 uM,24 h,2,71,0.2181,0.125831,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.3039,0.1912,-0.6026
CPC006_VCAP_6H:BRD-K32107296-001-03-7:10,BRD-K32107296,temozolomide,VCAP,trt_cp,10 uM,6 h,4,113,0.21,0.155768,1,0,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.2953,0.1678,-0.5854
REP.A018_HT29_24H:N18,BRD-K66615216,moxifloxacin,HT29,trt_cp,0.04 uM,24 h,3,132,0.2477,0.182844,0,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.2902,0.1568,-0.5754
CPC017_PHH_24H:BRD-K43389675-001-01-3:10,BRD-K43389675,daunorubicin,PHH,trt_cp,10 uM,24 h,2,356,0.57,0.455505,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.2871,0.1495,-0.5693
ASG001_PC3_6H:K24,BRD-K43797669,genistein,PC3,trt_cp,0.08 uM,6 h,2,124,0.341,0.207931,1,1,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.28,0.1317,-0.5551
CPC015_ASC_24H:BRD-K04548931-003-05-8:10,BRD-K04548931,epirubicin,ASC,trt_cp,10 uM,24 h,3,551,0.56,0.561695,0,0,1,1,0,Topoisomerase inhibitor,TOP2A|CHD1,-0.2785,0.1286,-0.5521
REP.A012_THP1_24H:C01,BRD-K00494077,trovafloxacin,THP1,trt_cp,10 uM,24 h,3,291,0.3962,0.343348,1,1,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.2758,0.1227,-0.5467
REP.A005_A375_24H:H19,BRD-K09471561,levofloxacin,A375,trt_cp,10 uM,24 h,3,83,0.1047,0.0942634,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.2653,0.1007,-0.526
REP.B011_MCF7_24H:C13,BRD-K04804440,ciprofloxacin,MCF7,trt_cp,2.22 uM,24 h,2,78,0.1267,0.100523,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.2628,0.0955,-0.5211
REP.B004_HA1E_24H:P09,BRD-A26423207,sparfloxacin,HA1E,trt_cp,0.25 uM,24 h,3,259,0.5086,0.367002,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.262,0.0941,-0.5194
CPC014_PHH_24H:BRD-K83794624-001-01-7:10,BRD-K83794624,pirarubicin,PHH,trt_cp,10 uM,24 h,4,158,0.11,0.133308,0,0,1,1,0,Topoisomerase inhibitor,TOP2A,-0.2562,0.0848,-0.5079
CPC017_ASC_24H:BRD-K43389675-001-01-3:10,BRD-K43389675,daunorubicin,ASC,trt_cp,10 uM,24 h,2,672,0.7,0.693528,0,0,1,1,0,RNA synthesis inhibitor|Topoisomerase inhibitor,TOP2A|TOP2B,-0.2547,0.0823,-0.505
CPC014_PHH_24H:BRD-K43797669-001-13-0:10,BRD-K43797669,genistein,PHH,trt_cp,10 uM,24 h,4,230,0.26,0.247276,0,0,1,1,0,Tyrosine kinase inhibitor,CFTR|ESR2|EGFR|ESR1|ESRRA|ESRRB|ESRRG|NCOA1|NCOA2|PPARG|PTK2B|TOP2A|TRPC5,-0.2482,0.0717,-0.4922
REP.B005_HT29_24H:O07,BRD-K11196887,norfloxacin,HT29,trt_cp,2.22 uM,24 h,2,142,0.3563,0.227448,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.2444,0.0661,-0.4846
REP.B024_MDAMB231_24H:L20,BRD-K78113049,enoxacin,MDAMB231,trt_cp,0.74 uM,24 h,2,79,0.0676,0.0738954,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.2441,0.0657,-0.484
REP.B009_HEK293_24H:K01,BRD-K32107296,temozolomide,HEK293,trt_cp,2.22 uM,24 h,2,139,0.2746,0.197555,1,1,1,1,0,DNA alkylating agent,TOP2A|MGMT,-0.2369,0.0555,-0.4697
CPC014_HCC515_6H:BRD-K66615216-001-01-9:10,BRD-K66615216,moxifloxacin,HCC515,trt_cp,10 uM,6 h,3,42,0.14,0.0775388,1,0,1,1,0,Bacterial DNA inhibitor,TOP2A,-0.2326,0.0496,-0.4612
PAC005_U2OS_6H:BRD-A75850590-003-04-9:10,BRD-A75850590,lomefloxacin,U2OS,trt_cp,10 uM,6 h,2,18,0.23,0.0650625,1,1,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.2272,0.0427,-0.4505
REP.B022_MCF10A_24H:O15,BRD-K82135108,elesclomol,MCF10A,trt_cp,0.25 uM,24 h,2,119,0.1731,0.145128,0,0,1,1,0,Oxidizing agent,TOP2A|HSPA1A,-0.2257,0.0404,-0.4475
REP.B011_MDAMB231_24H:C17,BRD-K04804440,ciprofloxacin,MDAMB231,trt_cp,0.03 uM,24 h,2,369,0.3072,0.340451,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.2244,0.0386,-0.445
REP.B011_YAPC_24H:C14,BRD-K04804440,ciprofloxacin,YAPC,trt_cp,0.74 uM,24 h,2,61,0.1161,0.0850965,0,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.2158,0.0297,-0.4279
CPC011_A375_6H:BRD-K55034111-066-12-2:10,BRD-K55034111,pefloxacin,A375,trt_cp,10 uM,6 h,3,147,0.1,0.1226,1,0,1,1,0,Bacterial DNA Gyrase inhibitor,TOP2A,-0.1645,0.0026,-0.3262
